Literature DB >> 15298739

The measurement of vitamin D: analytical aspects.

Joseph E Zerwekh1.   

Abstract

In the past quarter of a century, our understanding of the metabolism and mechanism of action of vitamin D has been elucidated. During this period, many metabolites of vitamin D have been identified and a small proportion of these assayed in blood. The ability to assay these vitamin D metabolites has led to a better appreciation of the pathological role that altered vitamin D metabolism plays in the development of diseases of calcium homeostasis. However, for many physicians it is not clear which vitamin D metabolites should be quantitated and what the information gained tells us. Of the four major circulating vitamin D metabolites in blood, only two, namely 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D [1,25(OH)(2)D], have warranted measurement. Of these, the need for assessing serum 1,25(OH)(2)D is actually quite limited and should therefore not be considered as part of the standard vitamin D testing regimen. 25OHD, on the other hand, provides us with the single best assessment of vitamin D nutritional status and should be the only vitamin D assay typically ordered for this reason. Which of the many methods that are available should a laboratory use for quantitating either of these vitamin D metabolites? Early methods required large volumes of blood, organic solvent extractions, and extensive purification of the vitamin D metabolites prior to assay. Today, these time-consuming and costly methods have given way to a range of radioimmunoassays and enzyme-linked immunosorbent assays that can accurately and conveniently provide important information concerning an individual's vitamin D status. This review will consider when vitamin D measurements should be undertaken and how best to perform such assays.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298739     DOI: 10.1258/0004563041201464

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  37 in total

1.  Improving the measurement of 25-hydroxyvitamin D.

Authors:  Andrew M Wootton
Journal:  Clin Biochem Rev       Date:  2005-02

2.  Development and comparison of three liquid chromatography-atmospheric pressure chemical ionization/mass spectrometry methods for determining vitamin D metabolites in human serum.

Authors:  Mary Bedner; Karen W Phinney
Journal:  J Chromatogr A       Date:  2012-04-05       Impact factor: 4.759

3.  Maternal vitamin D status and spontaneous preterm birth by placental histology in the US Collaborative Perinatal Project.

Authors:  Lisa M Bodnar; Mark A Klebanoff; Alison D Gernand; Robert W Platt; W Tony Parks; Janet M Catov; Hyagriv N Simhan
Journal:  Am J Epidemiol       Date:  2013-10-11       Impact factor: 4.897

4.  Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years.

Authors:  Lisa M Bodnar; Janet M Catov; Katherine L Wisner; Mark A Klebanoff
Journal:  Br J Nutr       Date:  2008-04-23       Impact factor: 3.718

5.  Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Pavel A Aronov; Laura M Hall; Katja Dettmer; Charles B Stephensen; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2008-04-24       Impact factor: 4.142

6.  Maternal vitamin D status and the risk of mild and severe preeclampsia.

Authors:  Lisa M Bodnar; Hyagriv N Simhan; Janet M Catov; James M Roberts; Robert W Platt; Jill C Diesel; Mark A Klebanoff
Journal:  Epidemiology       Date:  2014-03       Impact factor: 4.822

7.  Maternal vitamin D status and infant anthropometry in a US multi-centre cohort study.

Authors:  Cara L Eckhardt; Alison D Gernand; Daniel E Roth; Lisa M Bodnar
Journal:  Ann Hum Biol       Date:  2014-09-30       Impact factor: 1.533

8.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Authors:  B Littorin; P Blom; A Schölin; H J Arnqvist; G Blohmé; J Bolinder; A Ekbom-Schnell; J W Eriksson; S Gudbjörnsdottir; L Nyström; J Ostman; G Sundkvist
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

9.  Maternal and cord blood 25(OH)-vitamin D concentrations in relation to child development and behaviour.

Authors:  Sarah A Keim; Lisa M Bodnar; Mark A Klebanoff
Journal:  Paediatr Perinat Epidemiol       Date:  2014-06-17       Impact factor: 3.980

Review 10.  The use of fibroblast growth factor 23 testing in patients with kidney disease.

Authors:  Edward R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.